高血压是 COVID-19 患者死亡的主要预测因素：一项回顾性研究。
Hypertension the major predictor of mortality in COVID-19: A retrospective study.
机构信息
School of Nursing Payung Negeri, Pekanbaru, Riau, Indonesia.
出版信息
J Pak Med Assoc. 2024 May;74(5 (Supple-5)):S67-S69. doi: 10.47391/JPMA.Ind-RInC-18.
OBJECTIVE
To determine the role of comorbid diseases in patients with coronavirus disease-2019.
METHODS
The quantitative, retrospective study was conducted in July 2022 at Arifin Achmad Hospital, Riau, Indonesia, and comprised patients who died due to coronavirus disease-2019 between January and March 2021. Data was retrieved from the institutional medical records using a checklist that contained items related to demographic and comorbid data. Data was analysed using SPSS 27.
RESULTS
Of the 48 patients, 27(56.3%) were males, 21(43.7%) were females, and 20(41.7%) were aged 45-60 years. There were 16(33.3%) patients having hypertension, 11(22.9%) had diabetes mellitus, 5(10.4%) had both hypertension and diabetes mellitus, 5(10.4%) had asthma, and there was no co-morbidity in 11(22.9%) patients.
CONCLUSION
Hypertension was the most common comorbid disease among coronavirus disease-2019 who died.
目的
确定合并症在 2019 冠状病毒病患者中的作用。
方法
本定量、回顾性研究于 2022 年 7 月在印度尼西亚廖内省的阿利芬·阿赫马德医院进行，纳入了 2021 年 1 月至 3 月期间因 2019 冠状病毒病而死亡的患者。数据使用包含人口统计学和合并症数据相关项目的检查表从机构病历中检索。使用 SPSS 27 进行数据分析。
结果
48 例患者中，27 例（56.3%）为男性，21 例（43.7%）为女性，20 例（41.7%）年龄在 45-60 岁之间。16 例（33.3%）患者患有高血压，11 例（22.9%）患有糖尿病，5 例（10.4%）同时患有高血压和糖尿病，5 例（10.4%）患有哮喘，11 例（22.9%）患者无合并症。
结论
高血压是死于 2019 冠状病毒病的患者中最常见的合并症。
Zotero 插件